Europe Oncology Biosimilars Market Research Report Forecast 2017-2021

May 2017 | 108 pages | ID: EA291C4CAB8EN
S&P Consulting

Abstracts

The Europe Oncology Biosimilars Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Oncology Biosimilars industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Oncology Biosimilars market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

Key market segments and sub-segments
Evolving market trends and dynamics
Changing supply and demand scenarios
Quantifying market opportunities through market sizing and market forecasting
Tracking current trends/opportunities/challenges
Competitive insights
Opportunity mapping in terms of technological breakthroughs

Europe Oncology Biosimilars Market Analysis by Countries:

Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:

Covidien llc (Medtronic)
Johnson & Johnson MEDICAL
Bolton Surgical
Platts & Nisbett
Frankenman International
Changzhou Waston
Jiangsu Qianjing Medical
Changzhou Anker Medical
Changzhou Tongchuang Medical

Europe Oncology Biosimilars Market Analysis by Product:

Type 1
Type 2
Type 3

Europe Oncology Biosimilars Market Analysis by Application:

Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

Europe Oncology Biosimilars Sales Market Report Forecast 2017-2021

1 ONCOLOGY BIOSIMILARS MARKET OVERVIEW

1.1 Product Overview and Scope of Oncology Biosimilars
1.2 Classification of Oncology Biosimilars
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Oncology Biosimilars
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Oncology Biosimilars Market States Status and Prospect (2012-2021) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Oncology Biosimilars (2012-2021)
  1.5.1 Europe Oncology Biosimilars Sales and Growth Rate (2012-2021)
  1.5.2 Europe Oncology Biosimilars Revenue and Growth Rate (2012-2021)

2 EUROPE ECONOMIC IMPACT ON ONCOLOGY BIOSIMILARS INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 ONCOLOGY BIOSIMILARS MANUFACTURING COST ANALYSIS

3.1 Oncology Biosimilars Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Oncology Biosimilars

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Oncology Biosimilars Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015
4.4 Downstream Buyers

5 EUROPE ONCOLOGY BIOSIMILARS MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Oncology Biosimilars Market Competition by Manufacturers
  5.1.1 Europe Oncology Biosimilars Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Oncology Biosimilars Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Oncology Biosimilars (Volume and Value) by Type
  5.2.1 Europe Oncology Biosimilars Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Oncology Biosimilars Revenue and Market Share by Type (2012-2017)
5.3 Europe Oncology Biosimilars (Volume and Value) by Countries
  5.3.1 Europe Oncology Biosimilars Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Oncology Biosimilars Revenue and Market Share by Countries (2012-2017)
5.4 Europe Oncology Biosimilars (Volume) by Application

6 GERMANY ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Oncology Biosimilars Sales and Value (2012-2017)
  6.1.1 Germany Oncology Biosimilars Sales and Growth Rate (2012-2017)
  6.1.2 Germany Oncology Biosimilars Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Oncology Biosimilars Sales Price Trend (2012-2017)
6.2 Germany Oncology Biosimilars Sales and Market Share by Manufacturers
6.3 Germany Oncology Biosimilars Sales and Market Share by Type
6.4 Germany Oncology Biosimilars Sales and Market Share by Application

7 FRANCE ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

7.1 France Oncology Biosimilars Sales and Value (2012-2017)
  7.1.1 France Oncology Biosimilars Sales and Growth Rate (2012-2017)
  7.1.2 France Oncology Biosimilars Revenue and Growth Rate (2012-2017)
  7.1.3 France Oncology Biosimilars Sales Price Trend (2012-2017)
7.2 France Oncology Biosimilars Sales and Market Share by Manufacturers
7.3 France Oncology Biosimilars Sales and Market Share by Type
7.4 France Oncology Biosimilars Sales and Market Share by Application

8 UK ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

8.1 UK Oncology Biosimilars Sales and Value (2012-2017)
  8.1.1 UK Oncology Biosimilars Sales and Growth Rate (2012-2017)
  8.1.2 UK Oncology Biosimilars Revenue and Growth Rate (2012-2017)
  8.1.3 UK Oncology Biosimilars Sales Price Trend (2012-2017)
8.2 UK Oncology Biosimilars Sales and Market Share by Manufacturers
8.3 UK Oncology Biosimilars Sales and Market Share by Type
8.4 UK Oncology Biosimilars Sales and Market Share by Application

9 RUSSIA ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Oncology Biosimilars Sales and Value (2012-2017)
  9.1.1 Russia Oncology Biosimilars Sales and Growth Rate (2012-2017)
  9.1.2 Russia Oncology Biosimilars Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Oncology Biosimilars Sales Price Trend (2012-2017)
9.2 Russia Oncology Biosimilars Sales and Market Share by Manufacturers
9.3 Russia Oncology Biosimilars Sales and Market Share by Type
9.4 Russia Oncology Biosimilars Sales and Market Share by Application

10 ITALY ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Oncology Biosimilars Sales and Value (2012-2017)
  10.1.1 Italy Oncology Biosimilars Sales and Growth Rate (2012-2017)
  10.1.2 Italy Oncology Biosimilars Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Oncology Biosimilars Sales Price Trend (2012-2017)
10.2 Italy Oncology Biosimilars Sales and Market Share by Manufacturers
10.3 Italy Oncology Biosimilars Sales and Market Share by Type
10.4 Italy Oncology Biosimilars Sales and Market Share by Application

11 SPAIN ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Oncology Biosimilars Sales and Value (2012-2017)
  11.1.1 Spain Oncology Biosimilars Sales and Growth Rate (2012-2017)
  11.1.2 Spain Oncology Biosimilars Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Oncology Biosimilars Sales Price Trend (2012-2017)
11.2 Spain Oncology Biosimilars Sales and Market Share by Manufacturers
11.3 Spain Oncology Biosimilars Sales and Market Share by Type
11.4 Spain Oncology Biosimilars Sales and Market Share by Application

12 BENELUX ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Oncology Biosimilars Sales and Value (2012-2017)
  12.1.1 Benelux Oncology Biosimilars Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Oncology Biosimilars Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Oncology Biosimilars Sales Price Trend (2012-2017)
12.2 Benelux Oncology Biosimilars Sales and Market Share by Manufacturers
12.3 Benelux Oncology Biosimilars Sales and Market Share by Type
12.4 Benelux Oncology Biosimilars Sales and Market Share by Application

13 EUROPE ONCOLOGY BIOSIMILARS MANUFACTURERS ANALYSIS

13.1 Covidien llc (Medtronic)
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 Johnson & Johnson MEDICAL
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Bolton Surgical
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 Platts & Nisbett
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 Frankenman International
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 Changzhou Waston
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Jiangsu Qianjing Medical
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 Changzhou Anker Medical
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 Changzhou Tongchuang Medical
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE ONCOLOGY BIOSIMILARS MARKET FORECAST (2017-2021)

15.1 Germany Market Forecast (2017-2021)
15.2 France Market Forecast (2017-2021)
15.3 UK Market Forecast (2017-2021)
15.4 Russia Market Forecast (2017-2021)
15.5 Italy Market Forecast (2017-2021)
15.6 Spain Market Forecast (2017-2021)
15.7 Benelux Market Forecast (2017-2021)
15.8 Europe Oncology Biosimilars Market Forecast by Type (2017-2021)
15.9 Europe Oncology Biosimilars Market Forecast by Application (2017-2021)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Oncology Biosimilars
Table Classification of Oncology Biosimilars
Figure Europe Sales Market Share of Oncology Biosimilars by Type in 2015
Table Application of Oncology Biosimilars
Figure Europe Sales Market Share of Oncology Biosimilars by Application in 2015
Figure Germany Oncology Biosimilars Revenue and Growth Rate (2012-2021)
Figure France Oncology Biosimilars Revenue and Growth Rate (2012-2021)
Figure UK Oncology Biosimilars Revenue and Growth Rate (2012-2021)
Figure Russia Oncology Biosimilars Revenue and Growth Rate (2012-2021)
Figure Italy Oncology Biosimilars Revenue and Growth Rate (2012-2021)
Figure Spain Oncology Biosimilars Revenue and Growth Rate (2012-2021)
Figure Benelux Oncology Biosimilars Revenue and Growth Rate (2012-2021)
Figure Europe Oncology Biosimilars Sales and Growth Rate (2012-2021)
Figure Europe Oncology Biosimilars Revenue and Growth Rate (2012-2021)
Table Europe Oncology Biosimilars Sales of Key Manufacturers (2015 and 2016)
Table Europe Oncology Biosimilars Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Oncology Biosimilars Sales Share by Manufacturers
Figure 2016 Oncology Biosimilars Sales Share by Manufacturers
Table Europe Oncology Biosimilars Revenue by Manufacturers (2015 and 2016)
Table Europe Oncology Biosimilars Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Oncology Biosimilars Revenue Share by Manufacturers
Table 2016 Europe Oncology Biosimilars Revenue Share by Manufacturers
Table Europe Oncology Biosimilars Sales and Market Share by Type (2012-2017)
Table Europe Oncology Biosimilars Sales Share by Type (2012-2017)
Figure Sales Market Share of Oncology Biosimilars by Type (2012-2017)
Figure Europe Oncology Biosimilars Sales Growth Rate by Type (2012-2017)
Table Europe Oncology Biosimilars Revenue and Market Share by Type (2012-2017)
Table Europe Oncology Biosimilars Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oncology Biosimilars by Type (2012-2017)
Figure Europe Oncology Biosimilars Revenue Growth Rate by Type (2012-2017)
Table Europe Oncology Biosimilars Sales and Market Share by Countries (2012-2017)
Table Europe Oncology Biosimilars Sales Share by Countries (2012-2017)
Figure Sales Market Share of Oncology Biosimilars by Countries (2012-2017)
Table Europe Oncology Biosimilars Revenue and Market Share by Countries (2012-2017)
Table Europe Oncology Biosimilars Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Oncology Biosimilars by Countries (2012-2017)
Table Europe Oncology Biosimilars Sales and Market Share by Application (2012-2017)
Table Europe Oncology Biosimilars Sales Share by Application (2012-2017)
Figure Sales Market Share of Oncology Biosimilars by Application (2012-2017)
Figure Germany Oncology Biosimilars Sales and Growth Rate (2012-2017)
Figure Germany Oncology Biosimilars Revenue and Growth Rate (2012-2017)
Figure Germany Oncology Biosimilars Sales Price Trend (2012-2017)
Table Germany Oncology Biosimilars Sales by Manufacturers (2015 and 2016)
Table Germany Oncology Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Germany Oncology Biosimilars Sales by Type (2015 and 2016)
Table Germany Oncology Biosimilars Market Share by Type (2015 and 2016)
Table Germany Oncology Biosimilars Sales by Application (2015 and 2016)
Table Germany Oncology Biosimilars Market Share by Application (2015 and 2016)
Figure France Oncology Biosimilars Sales and Growth Rate (2012-2017)
Figure France Oncology Biosimilars Revenue and Growth Rate (2012-2017)
Figure France Oncology Biosimilars Sales Price Trend (2012-2017)
Table France Oncology Biosimilars Sales by Manufacturers (2015 and 2016)
Table France Oncology Biosimilars Market Share by Manufacturers (2015 and 2016)
Table France Oncology Biosimilars Sales by Type (2015 and 2016)
Table France Oncology Biosimilars Market Share by Type (2015 and 2016)
Table France Oncology Biosimilars Sales by Application (2015 and 2016)
Table France Oncology Biosimilars Market Share by Application (2015 and 2016)
Figure UK Oncology Biosimilars Sales and Growth Rate (2012-2017)
Figure UK Oncology Biosimilars Revenue and Growth Rate (2012-2017)
Figure UK Oncology Biosimilars Sales Price Trend (2012-2017)
Table UK Oncology Biosimilars Sales by Manufacturers (2015 and 2016)
Table UK Oncology Biosimilars Market Share by Manufacturers (2015 and 2016)
Table UK Oncology Biosimilars Sales by Type (2015 and 2016)
Table UK Oncology Biosimilars Market Share by Type (2015 and 2016)
Table UK Oncology Biosimilars Sales by Application (2015 and 2016)
Table UK Oncology Biosimilars Market Share by Application (2015 and 2016)
Figure Russia Oncology Biosimilars Sales and Growth Rate (2012-2017)
Figure Russia Oncology Biosimilars Revenue and Growth Rate (2012-2017)
Figure Russia Oncology Biosimilars Sales Price Trend (2012-2017)
Table Russia Oncology Biosimilars Sales by Manufacturers (2015 and 2016)
Table Russia Oncology Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Russia Oncology Biosimilars Sales by Type (2015 and 2016)
Table Russia Oncology Biosimilars Market Share by Type (2015 and 2016)
Table Russia Oncology Biosimilars Sales by Application (2015 and 2016)
Table Russia Oncology Biosimilars Market Share by Application (2015 and 2016)
Figure Italy Oncology Biosimilars Sales and Growth Rate (2012-2017)
Figure Italy Oncology Biosimilars Revenue and Growth Rate (2012-2017)
Figure Italy Oncology Biosimilars Sales Price Trend (2012-2017)
Table Italy Oncology Biosimilars Sales by Manufacturers (2015 and 2016)
Table Italy Oncology Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Italy Oncology Biosimilars Sales by Type (2015 and 2016)
Table Italy Oncology Biosimilars Market Share by Type (2015 and 2016)
Table Italy Oncology Biosimilars Sales by Application (2015 and 2016)
Table Italy Oncology Biosimilars Market Share by Application (2015 and 2016)
Figure Spain Oncology Biosimilars Sales and Growth Rate (2012-2017)
Figure Spain Oncology Biosimilars Revenue and Growth Rate (2012-2017)
Figure Spain Oncology Biosimilars Sales Price Trend (2012-2017)
Table Spain Oncology Biosimilars Sales by Manufacturers (2015 and 2016)
Table Spain Oncology Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Spain Oncology Biosimilars Sales by Type (2015 and 2016)
Table Spain Oncology Biosimilars Market Share by Type (2015 and 2016)
Table Spain Oncology Biosimilars Sales by Application (2015 and 2016)
Table Spain Oncology Biosimilars Market Share by Application (2015 and 2016)
Figure Benelux Oncology Biosimilars Sales and Growth Rate (2012-2017)
Figure Benelux Oncology Biosimilars Revenue and Growth Rate (2012-2017)
Figure Benelux Oncology Biosimilars Sales Price Trend (2012-2017)
Table Benelux Oncology Biosimilars Sales by Manufacturers (2015 and 2016)
Table Benelux Oncology Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Benelux Oncology Biosimilars Sales by Type (2015 and 2016)
Table Benelux Oncology Biosimilars Market Share by Type (2015 and 2016)
Table Benelux Oncology Biosimilars Sales by Application (2015 and 2016)
Table Benelux Oncology Biosimilars Market Share by Application (2015 and 2016)
Table Covidien llc (Medtronic) Basic Information List
Table Covidien llc (Medtronic) Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Covidien llc (Medtronic) Oncology Biosimilars Sales Market Share (2012-2017)
Table Johnson & Johnson MEDICAL Basic Information List
Table Johnson & Johnson MEDICAL Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Johnson & Johnson MEDICAL Oncology Biosimilars Sales Market Share (2012-2017)
Table Bolton Surgical Basic Information List
Table Bolton Surgical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bolton Surgical Oncology Biosimilars Sales Market Share (2012-2017)
Table Platts & Nisbett Basic Information List
Table Platts & Nisbett Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Platts & Nisbett Oncology Biosimilars Sales Market Share (2012-2017)
Table Frankenman International Basic Information List
Table Frankenman International Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Frankenman International Oncology Biosimilars Sales Market Share (2012-2017)
Table Changzhou Waston Basic Information List
Table Changzhou Waston Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Changzhou Waston Oncology Biosimilars Sales Market Share (2012-2017)
Table Jiangsu Qianjing Medical Basic Information List
Table Jiangsu Qianjing Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Jiangsu Qianjing Medical Oncology Biosimilars Sales Market Share (2012-2017)
Table Changzhou Anker Medical Basic Information List
Table Changzhou Anker Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Changzhou Anker Medical Oncology Biosimilars Sales Market Share (2012-2017)
Table Changzhou Tongchuang Medical Basic Information List
Table Changzhou Tongchuang Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Changzhou Tongchuang Medical Oncology Biosimilars Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology Biosimilars
Figure Manufacturing Process Analysis of Oncology Biosimilars
Figure Oncology Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015
Table Major Buyers of Oncology Biosimilars
Table Distributors/Traders List
Figure Germany Oncology Biosimilars Sales and Growth Rate Forecast (2017-2021)
Figure Germany Oncology Biosimilars Revenue and Growth Rate Forecast (2017-2021)
Figure France Oncology Biosimilars Sales and Growth Rate Forecast (2017-2021)
Figure France Oncology Biosimilars Revenue and Growth Rate Forecast (2017-2021)
Figure UK Oncology Biosimilars Sales and Growth Rate Forecast (2017-2021)
Figure UK Oncology Biosimilars Revenue and Growth Rate Forecast (2017-2021)
Figure Russia Oncology Biosimilars Sales and Growth Rate Forecast (2017-2021)
Figure Russia Oncology Biosimilars Revenue and Growth Rate Forecast (2017-2021)
Figure Italy Oncology Biosimilars Sales and Growth Rate Forecast (2017-2021)
Figure Italy Oncology Biosimilars Revenue and Growth Rate Forecast (2017-2021)
Figure Spain Oncology Biosimilars Sales and Growth Rate Forecast (2017-2021)
Figure Spain Oncology Biosimilars Revenue and Growth Rate Forecast (2017-2021)
Figure Benelux Oncology Biosimilars Sales and Growth Rate Forecast (2017-2021)
Figure Benelux Oncology Biosimilars Revenue and Growth Rate Forecast (2017-2021)
Table Europe Oncology Biosimilars Sales Forecast by Type (2017-2021)
Table Europe Oncology Biosimilars Sales Forecast by Application (2017-2021)

COMPANIES MENTIONED

Covidien llc (Medtronic), Johnson & Johnson MEDICAL, Bolton Surgical, Platts & Nisbett, Frankenman International, Changzhou Waston, Jiangsu Qianjing Medical, Changzhou Anker Medical, Changzhou Tongchuang Medical, Jiangsu Reable Medical, Changzhou Resource Medical, Jiangsu Kangjin Medical, Pfizer, Wockhardt